EMD Serono

229 articles with EMD Serono

• Merck Serono Fertility Treatment Pergoveris® Receives Marketing Approval in Russia

  3/16/2012

• Mendor Announces Partnership with Merck Serono in the UK

  2/14/2012

• Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility

  1/30/2012

• Ablynx and Merck Serono Select a Novel Nanobody Candidate, ALX-0761, for Pre-Clinical Development

  12/13/2011

• Ablynx Signs Discovery Pact Worth $69 Million With Merck Serono

  11/9/2011

• Merck Serono and Ono Pharmaceutical Company, Ltd. Sign Separate Agreements Worth $25 Million for MS and Cancer Drugs

  10/5/2011

• Merck Serono: New Data Inspire Global Experts to Call for Improved Education, Awareness and Support for Head and Neck Cancer Patients

  9/26/2011

• Merck Serono Buys Potential Copaxone Competitor from Bankrupt Peptimmune, Inc.

  9/19/2011

• Pharmaron LLC to Host Merck Serono Research and Development Laboratory in China

  9/14/2011

• f-Star, Merck Serono Sign $708 Million Deal for Antibody-Derived Therapeutics

  9/7/2011

• Merck Serono Opens Beijing Lab

  9/1/2011

• Merck Serono Reorganizes R&D, Attracts Former Bristol-Myers Squibb Company Medical Head

  7/8/2011

• Affectis Pharmaceuticals AG and Merck Serono Announce an Agreement to Develop Oral Drugs for Neurodegenerative Diseases

  6/8/2011

• Merck Serono Pays $44 Million to Settle Kickback Charge

  5/5/2011

• Merck Serono: Publication of Survival Benefit in Leading Journal Emphasizes Importance of Erbitux in 1st Line mCRC

  4/19/2011

• Merck Serono, Newron Pharmaceuticals: Safinamide Shows Promising Ph3 Results Against Dyskinesia

  4/14/2011

• Merck KGaA Eyes Job Cuts at Drug Unit Merck Serono

  4/12/2011

• Newron Pharmaceuticals and Merck Serono to Broaden Collaboration on New Therapies for Central Nervous System Diseases

  3/31/2011

• Merck Serono Expects M&A to Build China Sales

  3/31/2011

• Merck Serono: Erbitux Indication Extension Submitted for 1st-Line Advanced or Metastatic NSCLC in the EU

  3/30/2011